[{"Assets_0_FY_USD":489016000.0,"CommonStockSharesOutstanding_0_FY_shares":51852862.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-96239000.0,"NetIncomeLoss_1_FY_USD":-47590000.0,"NetIncomeLoss_4_FY_USD":-164981000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":51688383.0,"StockholdersEquity_0_FY_USD":392195000.0,"EarningsPerShareBasic_1_FY_USD":-0.92,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190225"}]